Covered recipient · General Payments record
DAVID F MARTIN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,540.47
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $947.12 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $485.13 | 24 |
| Janssen Scientific Affairs, LLC | $147.39 | 1 |
| Ipsen Biopharmaceuticals, Inc | $127.18 | 1 |
| Celgene Corporation | $64.81 | 3 |
| Gilead Sciences, Inc. | $37.86 | 2 |
| Fresenius Kabi USA, LLC | $27.60 | 1 |
| PFIZER INC. | $19.94 | 1 |
| Merck Sharp & Dohme Corporation | $19.23 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $17.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972859 | CMS |
| ABBVIE INC. | $18.76 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972861 | CMS |
| ABBVIE INC. | $20.01 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972863 | CMS |
| ABBVIE INC. | $28.97 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972865 | CMS |
| ABBVIE INC. | $19.39 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972867 | CMS |
| ABBVIE INC. | $3.34 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972869 | CMS |
| ABBVIE INC. | $22.54 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972871 | CMS |
| ABBVIE INC. | $2.94 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972873 | CMS |
| ABBVIE INC. | $33.46 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972875 | CMS |
| ABBVIE INC. | $3.48 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972877 | CMS |
| ABBVIE INC. | $21.63 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972879 | CMS |
| ABBVIE INC. | $125.00 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972881 | CMS |
| ABBVIE INC. | $3.32 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972883 | CMS |
| ABBVIE INC. | $30.08 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972885 | CMS |
| ABBVIE INC. | $3.91 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972887 | CMS |
| ABBVIE INC. | $34.82 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972889 | CMS |
| ABBVIE INC. | $3.04 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972891 | CMS |
| ABBVIE INC. | $3.21 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972893 | CMS |
| ABBVIE INC. | $22.22 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972895 | CMS |
| ABBVIE INC. | $18.26 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972897 | CMS |
| ABBVIE INC. | $1.91 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972899 | CMS |
| ABBVIE INC. | $15.90 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972901 | CMS |
| ABBVIE INC. | $16.95 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972903 | CMS |
| ABBVIE INC. | $29.07 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972905 | CMS |
| Celgene Corporation | $25.43 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101124052 | CMS |
| Celgene Corporation | $15.14 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101124058 | CMS |
| Celgene Corporation | $24.24 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101124064 | CMS |
| Fresenius Kabi USA, LLC | $27.60 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146945429 | CMS |
| Gilead Sciences, Inc. | $18.83 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133778540 | CMS |
| Gilead Sciences, Inc. | $19.03 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133778542 | CMS |
| Intercept Pharmaceuticals, Inc. | $17.98 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113632584 | CMS |
| Ipsen Biopharmaceuticals, Inc | $127.18 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091992219 | CMS |
| Janssen Scientific Affairs, LLC | $147.39 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078854128 | CMS |
| Merck Sharp & Dohme LLC | $19.23 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141576733 | CMS |
| PFIZER INC. | $19.94 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131516063 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.